Particularly, spending for controller drugs grew from $280 million to $2.1 billion and for reliever drugs, the increase was $222 million to $352 million . Source Company for Health care Quality and Research.. AHRQ: As...

Soliris isn't approved in virtually any country to take care of MG. Alexion is enrolling patients in a multinational, placebo-controlled registration trial of eculizumab in individuals with refractory generalized MG. ...

They examined 723 people, ages 65 to 90 years, who had been categorized as either normal cognitively, with slight cognitive impairment or suffering from full-blown AD. 'We found that younger elderly show higher prices...

But the figure soared to 70.6 percent among 16 to 24 year olds of whom only 7.7 per cent avoid obtaining a tan. Cancer Research UK researchers, investigating attitudes to sunlight protection in teenagers, recently fou...